ORIGINALS | |
Role of “health-related quality of life” measurements in the design of drug clinical trials
R. San Miguel, V. del Villar, C. Pérez, M. de Frutos, J. Mar, M.J. Coma Farm Hosp. 2010;34:16-22. |
|